Thyroid

Thyroid Medication: The Complete Guide

Thyroid medication compared: levothyroxine, liothyronine, combination therapy and desiccated thyroid, plus absorption, dosing and FDA status.

By Dr. Samia McCully, ND · Updated October 23, 2026

Thyroid medication is hormone replacement that restores the thyroid hormone an underactive gland no longer supplies, and it forms the core treatment for hypothyroidism. The category includes synthetic T4 (levothyroxine), synthetic T3 (liothyronine), combinations of the two, and desiccated thyroid extract made from pig thyroid glands. Levothyroxine ranked third among all U.S. prescriptions in 2023, at about 81 million, according to ClinCalc. The options differ in their T4-to-T3 ratio, dosing precision, evidence base and regulatory status, and absorption problems undermine many doses. Thyroid health care matches the medication and dose to labs, symptoms and life stage.

Synthetic T4: Levothyroxine

Levothyroxine is a synthetic copy of T4, the storage hormone the thyroid gland makes, and the body converts it into active T3 in tissues such as the liver, kidneys and muscle. The American Thyroid Association's 2014 guideline recommends levothyroxine as the standard treatment for hypothyroidism. Its main features:

Brands and forms. Synthroid, Levoxyl, Unithroid and generic tablets, plus liquid and gel-capsule forms such as Tirosint for people with absorption problems.
Long half-life. T4 has a half-life of about one week, which produces steady blood levels with once-daily dosing.
Weight-based dosing. Full replacement averages about 1.6 micrograms per kilogram of body weight per day, with lower starting doses in older adults and people with heart disease.
Monitoring. TSH is rechecked about 6 to 8 weeks after each dose change, the time needed to reach a new steady state.
Dependence on conversion. Levothyroxine works through the body's own T4-to-T3 conversion.

That last feature explains a common pattern. Dr. Samia McCully reports in a video on the Wellness Architecture YouTube channel that some patients taking synthetic T4 under-convert it, which leaves them hypothyroid in how they feel despite a normal TSH. A complete thyroid panel with free T3 and reverse T3 detects this pattern.

Synthetic T3: Liothyronine

Liothyronine is a synthetic copy of T3, the active thyroid hormone, sold as Cytomel and generics. It bypasses conversion and acts within hours. Its properties shape how it is used:

Short half-life. T3 has a half-life of about one day, so levels rise and fall within each day.
Divided dosing. Many regimens split the daily dose into two to smooth those peaks.
Side effects at peaks. Palpitations, anxiety and heat intolerance appear when levels peak too high.
Role in combination. Liothyronine usually joins levothyroxine rather than replacing it.
Research. Sustained-release T3 formulations are under study to reduce peaks.

Liothyronine alone rarely serves as long-term therapy outside special situations, because its short action makes stable levels difficult to maintain.

Combination Therapy and Desiccated Thyroid

Combination and natural products supply both T4 and T3, aiming to replicate what a healthy thyroid releases. The options compare as follows:

Medication	Hormones	T4:T3 ratio	Dosing	FDA status
Levothyroxine (Synthroid, generics)	T4	T4 only	Once daily	Approved
Liothyronine (Cytomel, generics)	T3	T3 only	Once or twice daily	Approved
LT4 plus LT3 combination	T4 and T3	Set by prescriber	Daily, often split T3	Each component approved
Desiccated thyroid (Armour Thyroid, NP Thyroid)	T4 and T3 from pig thyroid	About 4.2:1	Once or twice daily	Not FDA approved; status under review
Human thyroid secretion (reference)	T4 and T3	About 14:1	Continuous	Not applicable

The ratio figures come from the ATA 2014 guideline. A 2021 consensus of the American, British and European thyroid associations reviewed 14 trials of LT4/LT3 combination therapy, found no consistent benefit, and called for new trials focused on patients dissatisfied with levothyroxine. A common conversion places 60 mg of desiccated thyroid near 100 micrograms of levothyroxine, with TSH rechecked about six weeks after any switch.

Dosing and Monitoring of Thyroid Medication

Dosing and monitoring keep thyroid medication within a window where symptoms resolve and overtreatment risks stay low. Five principles guide adjustment:

TSH as the main dose guide for levothyroxine, checked 6 to 8 weeks after each change and once or twice a year when stable.
Free T4 and free T3 as added information, especially when symptoms and TSH disagree or when T3 is part of treatment.
Symptom tracking, since energy, temperature tolerance, bowel habits and mood show response alongside labs.
Avoiding overtreatment. A suppressed TSH from excess hormone raises the risk of atrial fibrillation and bone loss, particularly in women after menopause.
Life-stage changes. Pregnancy raises dose requirements early, and oral estrogen raises them as well (Arafah, New England Journal of Medicine, 2001).

Wellness Architecture's 20-marker Custom Wellness Panel includes TSH, free and total T4, free and total T3, reverse T3 and T3 uptake, which allows conversion to be tracked during treatment. The practice prescribes thyroid medication when results and symptoms support it.

Absorption Factors That Affect Thyroid Medication

Absorption determines how much of each thyroid dose reaches the bloodstream, and several everyday factors reduce it. The factors that matter most:

Timing with food. Levothyroxine absorbs most completely on an empty stomach, 30 to 60 minutes before breakfast, or at bedtime several hours after the last meal.
Coffee. Coffee taken with levothyroxine tablets lowers absorption.
Calcium and iron. These supplements bind thyroid hormone in the gut; a separation of about four hours protects absorption.
Gut conditions. Celiac disease, low stomach acid and acid-suppressing medications reduce absorption of tablets.
Oral estrogen. Oral estradiol raises thyroxine-binding globulin and increases the dose needed, while transdermal estrogen has less effect.

Consistency matters more than any single rule. Taking the dose the same way every day keeps blood levels stable and makes lab results interpretable.

Levothyroxine Is the Guideline-Recommended First Treatment

Levothyroxine holds first-line status in the American Thyroid Association's 2014 guideline because it offers precise dosing, a long half-life, stable blood levels and decades of outcome data. Most people with hypothyroidism feel well on it once the dose is right. Its reliance on the body's conversion of T4 to T3 explains why a subset of patients continue to have symptoms, which is the group that prompts discussion of T3 and combination options.

Desiccated Thyroid Supplies More T3 Than the Human Thyroid Makes

Desiccated thyroid extract delivers T4 and T3 at about a 4.2 to 1 ratio, while the human thyroid secretes them at roughly 14 to 1, according to the ATA 2014 guideline. The higher T3 share produces faster action and, in some patients, peaks that cause palpitations or anxiety. Because the product comes from animal glands, hormone content varies more than in synthetic tablets. Some patients report feeling better on it, which drives its continued use.

Combination Therapy Has Not Shown Consistent Benefit in Trials

Trials of combination T4 and T3 therapy have produced mixed results. The 2021 consensus counted 14 trials without consistent benefit, while noting that many patients and clinicians report improvement in practice. The 2013 crossover trial by Hoang and colleagues gave 70 adults desiccated thyroid and levothyroxine for 16 weeks each: 48.6 percent preferred desiccated thyroid, 18.6 percent preferred levothyroxine, and symptom scores did not differ, though the desiccated group lost about 3 pounds. Preference and measured outcomes therefore point in different directions.

Absorption Problems Undermine Many Thyroid Doses

Absorption problems explain many cases of rising doses, fluctuating labs and persistent symptoms. Coffee, calcium, iron, food timing, gut conditions and acid-suppressing medications all reduce the share of levothyroxine that reaches the blood. Changing how a pill is taken often stabilizes TSH without changing the dose. Liquid and gel-capsule formulations help people whose absorption problems persist despite correct timing.

Desiccated Thyroid Faces an Unsettled Regulatory Status

Desiccated thyroid extract has never received FDA approval, and its regulatory status changed in 2025. The FDA sent letters in August 2025 to manufacturers of unapproved animal-derived thyroid products, including Armour Thyroid and NP Thyroid, signaling future enforcement while allowing time for patients to transition. Later statements indicated that the agency intended to pursue a pathway to approval and to issue compliance guidance by August 2026. Patients taking desiccated thyroid benefit from discussing a plan with their prescriber in case supply or status changes.

Frequently Asked Questions

What is the difference between Synthroid and Armour Thyroid?

Synthroid is synthetic levothyroxine, containing only T4, with precise FDA-approved dosing. Armour Thyroid is desiccated pig thyroid containing T4 and T3 at about a 4.2 to 1 ratio. Armour acts faster through its T3 content, but its dosing varies more and it lacks FDA approval.

How long does thyroid medication take to work?

Thyroid medication begins working within days, but levothyroxine takes about 6 to 8 weeks to reach a steady level, which is when TSH is rechecked. Many people notice energy improving over the first several weeks, with full benefit after the dose is optimized across one or more adjustments.

What time of day is thyroid medication taken?

Levothyroxine is usually taken on an empty stomach with water, 30 to 60 minutes before breakfast, or at bedtime several hours after eating. Coffee, calcium and iron reduce absorption, so they are separated from the dose. Taking it the same way every day keeps levels stable.

Is desiccated thyroid FDA approved?

Desiccated thyroid extract, including Armour Thyroid and NP Thyroid, is not FDA approved. In August 2025 the FDA sent letters signaling future enforcement against unapproved animal-derived thyroid products, and later statements described a path toward possible approval with guidance expected by August 2026.

Why does thyroid medication not resolve symptoms for everyone?

Thyroid medication leaves some people symptomatic because of poor T4-to-T3 conversion, absorption problems, an imprecise dose or a second condition such as iron deficiency, sleep apnea or perimenopause. A complete thyroid panel and a review of how the medication is taken identify most of these causes.

Common Misconceptions About Thyroid Medication

Misconception: Natural Desiccated Thyroid Is Identical To Human Thyroid Hormone

Desiccated thyroid comes from pig glands and contains T4 and T3 at about a 4.2 to 1 ratio, compared with roughly 14 to 1 secreted by the human thyroid. The hormones themselves match human molecules, but the proportions and batch consistency differ.

Misconception: Higher Doses Always Mean Better Energy

Excess thyroid hormone causes palpitations, anxiety, insomnia and heat intolerance, and long-term overtreatment raises the risk of atrial fibrillation and bone loss. The goal is the dose that resolves symptoms while keeping labs in a safe range.

Misconception: Brand And Generic Levothyroxine Are Interchangeable At Will

Brand and generic levothyroxine contain the same hormone, but small differences between products change blood levels in some patients. Guidelines favor staying on one product and rechecking TSH about six weeks after any switch.

Misconception: Thyroid Medication Works Within Days

Levothyroxine has a half-life of about one week and takes 6 to 8 weeks to reach a steady level. Lab checks earlier than that do not reflect the full effect of a dose. Symptom improvement builds over weeks and dose adjustments.

Misconception: Thyroid Medication Causes Weight Loss

Thyroid medication restores normal metabolism in people with hypothyroidism, which reverses the modest weight gain, much of it fluid, that hypothyroidism causes. It does not produce weight loss beyond that, and using excess thyroid hormone for weight loss carries serious risks.

Ongoing Debates in Thyroid Medication

Combination therapy divides experts. Supporters cite patients who feel better with added T3 and genetic differences in conversion enzymes. Critics cite 14 trials without consistent benefit and favor levothyroxine alone.

Desiccated thyroid draws sharp disagreement. Patients and some clinicians value it for preference and symptom relief. Endocrine societies favor synthetic products for precise dosing, and the FDA has signaled regulatory action.

Dosing targets split clinicians. One group doses primarily to TSH within the reference range. The other group adjusts toward symptom relief and free T3, accepting a lower TSH within safe limits.

Brand versus generic levothyroxine remains debated. Some clinicians keep patients on one brand for consistency. Others consider generics equivalent and switch based on cost.

The role of T3 in persistent symptoms continues to evolve. Some researchers point to sustained-release T3 as a future solution. Others argue that persistent symptoms often stem from other conditions rather than T3 deficiency.

Components of Thyroid Medication Therapy

Thyroid medication therapy contains several interacting parts. Levothyroxine forms the core component of standard hypothyroidism treatment, supplying T4 for the body to convert. Liothyronine forms a component of combination therapy, adding active T3 directly. T3 forms a component of desiccated thyroid extract, present at a higher share than the human gland secretes. TSH monitoring forms a component of dose titration, guiding adjustments every 6 to 8 weeks. Timing forms a component of levothyroxine absorption, and coffee, calcium, iron and food all alter it. Successful treatment depends on aligning all of these parts rather than on the choice of pill alone.

Summary

Thyroid medication restores missing hormone through levothyroxine, liothyronine, combination therapy or desiccated thyroid extract, each with different ratios, dosing and regulatory status. Synthetic T4, synthetic T3, combination products, dosing and absorption together determine results. Levothyroxine is the guideline-recommended first treatment, while desiccated thyroid supplies more T3 than the human thyroid makes and faces an unsettled FDA status. Thyroid health care aligns medication, dose and absorption with a complete panel.